Gara Jalqabaatti › Saree (Gosoota Hunda) › Virginia › Arlington
Qorannoo klinikaalii Saree (Gosoota Hunda) Arlington, VA keessatti
Qorannoo 48 Saree (Gosoota Hunda) f Arlington fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
Namoota walitti qabaa jiraSadarkaa 3
- Inova Schar Cancer Institute, Fairfax · Miili 11 fagaatti
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 2/3
- Virginia Cancer Specialists - Fairfax /ID# 275071, Fairfax · Miili 11 fagaatti
Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
Namoota walitti qabaa jiraSadarkaa 1/2
- NEXT Virginia, Fairfax · Miili 11 fagaatti
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
Namoota walitti qabaa jiraSadarkaa 2
- Virginia Cancer Specialists ( Site 1102), Fairfax · Miili 11 fagaatti
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Namoota walitti qabaa jiraSadarkaa 2
- Next Virginia /ID# 279684, Fairfax · Miili 11 fagaatti
A Study of ASP3082 in Adults With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · Miili 11 fagaatti
REC-7735 in Participants With Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- NEXT Virginia, Fairfax · Miili 11 fagaatti
A Study of PHN-012 in Patients With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- PHN-012-001 Site, Fairfax · Miili 11 fagaatti
Registry Study for Radiation Therapy Outcomes
Namoota walitti qabaa jiraQorannoo ilaalaa
- Inova Schar Cancer Institute, Fairfax · Miili 11 fagaatti
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- NEXT Oncology, Fairfax · Miili 11 fagaatti
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Inova Schar Cancer Institute Clinical Trials, Fairfax · Miili 11 fagaatti
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Virginia Cancer Specialists - Fairfax /ID# 280710, Fairfax · Miili 11 fagaatti
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Inova Schar Cancer Institute, Fairfax · Miili 11 fagaatti
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- NEXT Oncology Virginia, Fairfax · Miili 11 fagaatti
A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
Namoota walitti qabaa jiraSadarkaa 1
- NEXT Virginia ( Site 0054), Fairfax · Miili 11 fagaatti
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
Namoota walitti qabaa jiraSadarkaa 1
- Investigational Site number: 404, Fairfax · Miili 11 fagaatti
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Namoota walitti qabaa jiraSadarkaa 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · Miili 11 fagaatti
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- NEXT Oncology, Fairfax · Miili 11 fagaatti
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- USO - Virginia Cancer Specialists, Fairfax · Miili 11 fagaatti
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- NEXT Virginia, Fairfax · Miili 11 fagaatti
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
Namoota walitti qabaa jiraSadarkaa 1
- NEXT Oncology, Fairfax · Miili 11 fagaatti
Project: Every Child for Younger Patients With Cancer
Namoota walitti qabaa jiraQorannoo ilaalaa
- Inova Fairfax Hospital, Falls Church · Miili 4 fagaatti
A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
Namoota walitti qabaa jiraSadarkaa 1
- NEXT Oncology Virginia, Fairfax · Miili 11 fagaatti
A Study of ASP1002 in Adults for Treatment of Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- NEXT Oncology Virginia, Fairfax · Miili 11 fagaatti
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Namoota walitti qabaa jiraSadarkaa 2
- 522, Fairfax · Miili 11 fagaatti
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Virginia Cancer Specialists, Fairfax · Miili 11 fagaatti
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Namoota walitti qabaa jiraSadarkaa 1
- Virginia Cancer Specialists - Fairfax /ID# 268559, Fairfax · Miili 11 fagaatti
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Namoota walitti qabaa jiraSadarkaa 2
- Inova Schar Cancer Institute - Fairfax - Innovation Park Drive /ID# 274586, Fairfax · Miili 11 fagaatti
- Virginia Cancer Specialists - Fairfax /ID# 274339, Fairfax · Miili 11 fagaatti
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- USO-Virginia Cancer Specialists, PC, Fairfax · Miili 11 fagaatti
Burn Pit Exposure in Veterans: A Cancer Screening Pilot Study at the Inova Saville Cancer Screening & Prevention Center
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
- Inova Schar Cancer Institute, Fairfax · Miili 11 fagaatti
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Namoota walitti qabaa jiraSadarkaa 1/2
- NEXT Oncology Virginia, Fairfax · Miili 11 fagaatti
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- NEXT, Fairfax · Miili 11 fagaatti
Occupational Cancer Screening in Firefighters: A Pilot Study Within the Inova Health System
Namoota walitti qabaa jira
- Inova Schar Cancer - Saville Cancer Screening and Prevention Center, Fairfax · Miili 11 fagaatti
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Namoota walitti qabaa jiraSadarkaa 1
- Research Site, Fairfax · Miili 11 fagaatti
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- NEXT Oncology Virginia, Fairfax · Miili 11 fagaatti
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- NEXT Virginia, Fairfax · Miili 11 fagaatti
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
Namoota walitti qabaa jiraSadarkaa 1/2
- NEXT Virginia, Fairfax · Miili 11 fagaatti
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- NEXT Oncology - Virginia, Fairfax · Miili 11 fagaatti
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- NEXT Virginia, Fairfax · Miili 11 fagaatti
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- NEXT Oncology Virginia, Fairfax · Miili 11 fagaatti
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- NEXT Virginia, Fairfax · Miili 11 fagaatti
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- NEXT Oncology, Fairfax · Miili 11 fagaatti
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- NEXT Virginia, Fairfax · Miili 11 fagaatti
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- NEXT Virigina, Fairfax · Miili 11 fagaatti
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Virginia Cancer Specialists, Fairfax · Miili 11 fagaatti
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
- Virginia Cancer Specialists, Fairfax · Miili 11 fagaatti
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
Namoota walitti qabaa jiraSadarkaa 1/2
- NEXT Virginia, Fairfax · Miili 11 fagaatti
A Study in Patients With Advanced Cancers
Namoota walitti qabaa jiraSadarkaa 1/2
- NEXT Oncology Virginia, Fairfax · Miili 11 fagaatti
Qorannoo Saree (Gosoota Hunda) magaalota biroo keessatti
- Houston, TXQorannoo 121
- New York City, NYQorannoo 109
- Boston, MAQorannoo 85
- Los Angeles, CAQorannoo 74
- Nashville, TNQorannoo 65
- Philadelphia, PAQorannoo 59
- Washington, DCQorannoo 58
- Durham, NCQorannoo 58
- Chicago, ILQorannoo 51
- Atlanta, GAQorannoo 49
- Seattle, WAQorannoo 49
- St. Louis, MOQorannoo 46
Qorannoo biroo Arlington keessatti
- Kansara Qara'a Non-Small CellQorannoo 104
- Kansara MetastatikiiQorannoo 53
- Kansarii ColorectalQorannoo 52
- Saree OljooQorannoo 47
- Kansarii OvariiQorannoo 46
- Dhibee QaraQorannoo 41
- Kansa EndometiriyaaliiQorannoo 39
- Kansarii PancreasQorannoo 33
- Kansa Selii Skwaamoo Mataa fi MormaQorannoo 26
- Kansarii Hafuu Seli XiqqaaQorannoo 23
- Kanisa HarkaaQorannoo 20
- Kansaar Onnee Triple-NegativeQorannoo 20
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.